TNFRSF4 and B-cell non-Hodgkin lymphoma: Additionally, a phase 1 study of IT SD-101 in combination with anti-OX40 antibody BMS 986178 and local low-dose radiation therapy using high-energy X-rays, is ongoing for patients with low-grade B-cell NHL (NCT03410901).